Mikael Eriksson

11 – 20 of 155

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/c0aca914-d0d5-4bd6-ba1a-cc3dcbf7e8f1?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
3
4
5
…
16
next »

2022
Mark SELNET clinical practice guidelines for soft tissue sarcoma and GIST
Blay, J.Y. ; Eriksson, M. ^LU and Martin-Broto, Javier (2022) In Cancer Treatment Reviews 102.
- Contribution to journal › Scientific review
Mark Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments
Stacchiotti, Silvia ; Eriksson, M. ^LU and Wagner, A.J. (2022) In Cancer Treatment Reviews 110.
- Contribution to journal › Article
Mark SELNET clinical practice guidelines for bone sarcoma
Blay, J.Y. ; Eriksson, M. ^LU and Martin-Broto, Javier (2022) In Critical Reviews in Oncology/Hematology 174.
- Contribution to journal › Article
2021
Mark Adjuvant imatinib for GIST : duration likely matters
Eriksson, M. ^LU and Joensuu, H. (2021) In Annals of Oncology 32(4). p.434-436
- Contribution to journal › Debate/Note/Editorial
Mark Benefit of pazopanib in advanced gastrointestinal stromal tumours: results from a phase II trial (SSG XXI, PAGIST)
Eriksson, Mikael ^LU ; Reichardt, P. ; Joensuu, H ; Krarup-Hansen, A. ; Hagberg, Oskar ^LU ; Hohenberger, P. ; Hagberg, H ; Hansson, L ; Foukakis, Theodoros and Pulkkanen, K. , et al. (2021) In ESMO Open 6(4).
- Contribution to journal › Article
Mark Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities
Stacchiotti, S. ; Eriksson, Mikael ^LU and Trama, Annalisa (2021) In Cancer 127(16). p.2934-2942
- Contribution to journal › Article
Mark Epithelioid hemangioendothelioma, an ultra-rare cancer : a consensus paper from the community of experts
Stacchiotti, S. ; Miah, A. B. ; Frezza, A. M. ; Messiou, C. ; Morosi, C. ; Caraceni, A. ; Antonescu, C. R. ; Bajpai, J. ; Baldini, E. and Bauer, S. , et al. (2021) In ESMO Open 6(3).
- Contribution to journal › Scientific review
Mark Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy : Results from the EUROpean Bone Over 40 Sarcoma Study
Hompland, Ivar ; Ferrari, Stefano ; Bielack, Stefan ; Palmerini, Emanuela ; Hall, Kirsten S. ; Picci, Pierro ; Hecker-Nolting, Stefanie ; Donati, Davide M. ; Blattmann, Claudia and Bjerkehagen, Bodil , et al. (2021) In European Journal of Cancer 151. p.150-158
- Contribution to journal › Article
2020
Mark Survival Outcomes Associated with 3 Years vs 1 Year of Adjuvant Imatinib for Patients with High-Risk Gastrointestinal Stromal Tumors : An Analysis of a Randomized Clinical Trial after 10-Year Follow-up
Joensuu, Heikki ; Eriksson, Mikael ^LU ; Sundby Hall, Kirsten ; Reichardt, Annette ; Hermes, Barbara ; Schütte, Jochen ; Cameron, Silke ; Hohenberger, Peter ; Jost, Philipp J. and Al-Batran, Salah Eddin , et al. (2020) In JAMA Oncology 6(8). p.1241-1246
- Contribution to journal › Article
Mark Rare cancers of unknown etiology : lessons learned from a European multi-center case–control study
Lynge, Elsebeth ; Kaerlev, Linda ; Olsen, Jørn ; Sabroe, Svend ; Afonso, Noemia ; Ahrens, Wolfgang ; Eriksson, Mikael ^LU ; Merletti, Franco ; Morales-Suarez-Varelas, Maria and Stengrevics, Aivars , et al. (2020) In European Journal of Epidemiology 35(10). p.937-948
- Contribution to journal › Article

« previous
1
2
3
4
5
…
16
next »